Land: Singapur
Sprache: Englisch
Quelle: HSA (Health Sciences Authority)
Pregabalin
PFIZER PFE PRIVATE LIMITED
N03AX16
300.00mg
CAPSULE
Pregabalin 300.00mg
ORAL
Prescription Only
Pfizer Manufacturing Deutschland GmbH
ACTIVE
2005-05-12
Page 1 of 12 LYRICA ® CAPSULES (Pregabalin) 1. NAME OF THE MEDICINAL PRODUCT LYRICA ® 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each hard capsule contains 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, or 300 mg of pregabalin. _ _ 3. PHARMACEUTICAL FORM 25 mg: Size 4, white opaque/white opaque hard gelatin capsule containing a white to off-white powder with PGN 25 printed on the body and Pfizer printed on the cap. 50 mg: Size 3, white opaque/white opaque hard gelatin capsule with a black band containing a white to off-white powder with PGN 50 printed on the body and Pfizer printed on the cap. 75 mg: Size 4, white opaque/orange opaque hard gelatin capsule containing a white to off-white powder with PGN 75 printed on the body and Pfizer printed on the cap. 100 mg: Size 3, orange opaque/orange opaque hard gelatin capsule containing a white to off-white powder with PGN 100 printed on the body and Pfizer printed on the cap. 150 mg: Size 2 white opaque/white opaque hard gelatin capsule containing a white to off-white powder with PGN 150 printed on the body and Pfizer printed on the cap. 200 mg: Size 1 light orange opaque/light orange opaque hard gelatin capsule containing a white to off-white powder with PGN 200 printed on the body and Pfizer printed on the cap. 300 mg: Size 0 white opaque/orange opaque hard gelatin capsule containing a white to off-white powder with PGN 300 printed on the body and Pfizer printed on the cap. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Neuropathic pain Pregabalin is indicated for the treatment of neuropathic pain which includes diabetic peripheral neuropathy and post-herpetic neuralgia in adults. Epilepsy Pregabalin is indicated as adjunctive therapy of partial seizures, Lesen Sie das vollständige Dokument
LYRICA ® CAPSULES (Pregabalin) 1. NAME OF THE MEDICINAL PRODUCT LYRICA ® 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each hard capsule contains 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, or 300 mg of pregabalin. 3. PHARMACEUTICAL FORM 25 mg: Size 4, white opaque/white opaque hard gelatin capsule containing a white to off-white powder with PGN 25 printed on the body and Pfizer printed on the cap. 50 mg: Size 3, white opaque/white opaque hard gelatin capsule with a black band containing a white to off-white powder with PGN 50 printed on the body and Pfizer printed on the cap. 75 mg: Size 4, white opaque/orange opaque hard gelatin capsule containing a white to off-white powder with PGN 75 printed on the body and Pfizer printed on the cap. 100 mg: Size 3, orange opaque/orange opaque hard gelatin capsule containing a white to off-white powder with PGN 100 printed on the body and Pfizer printed on the cap. 150 mg: Size 2 white opaque/white opaque hard gelatin capsule containing a white to off-white powder with PGN 150 printed on the body and Pfizer printed on the cap. 200 mg: Size 1 light orange opaque/light orange opaque hard gelatin capsule containing a white to off-white powder with PGN 200 printed on the body and Pfizer printed on the cap. 300 mg: Size 0 white opaque/orange opaque hard gelatin capsule containing a white to off-white powder with PGN 300 printed on the body and Pfizer printed on the cap. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Neuropathic pain Pregabalin is indicated for the treatment of neuropathic pain, which includes diabetic peripheral neuropathy and post-herpetic neuralgia, in adults. Epilepsy Pregabalin is indicated as adjunctive therapy of partial seizures, with or without secondary generalisation, in adults. Generalised anxiety disorder Pregabalin is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults. Fibromyalgia Pregabalin is indicated for the management of fibromyalgia. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The dose range is 150 to 600 mg per da Lesen Sie das vollständige Dokument